Compositions and methods for enhancing drug delivery across and into epithelial tissues

Details for Australian Patent Application No. 2002303102 (hide)

Owner CELLGATE, INC.

Inventors Rothbard, Jonathan B.; Sista, Lalitha V. S.; Kirschberg, Thorsten A.; Wender, Paul A.; McGrane, P. Leo

Agent Spruson & Ferguson

Pub. Number AU-A-2002303102

PCT Number PCT/US02/05829

PCT Pub. Number WO2002/069930

Priority 09/792,480 23.02.01 US

Filing date 25 February 2002

Wipo publication date 19 September 2002

International Classifications

A61K 009/02 Medicinal preparations characterised by special physical form - Suppositories

C07C 257/00 Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines

C07C 279/00 Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups

C07K 004/00 Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 014/00 Peptides having more than 20 amino acids

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 038/03 Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 038/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 09/792,480 23.02.01 US

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002303102

10 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303103-COMPOSITIONS AND METHODS OF MANUFACTURE FOR ORAL DISSOLVABLE DOSAGE FORMS

2002303101-Methods and compositions for modifying apolipoprotein B mRNA editing